Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5G5J

Crystal structure of human CYP3A4 bound to metformin

Summary for 5G5J
Entry DOI10.2210/pdb5g5j/pdb
DescriptorCYTOCHROME P450 3A4, Metformin, PROTOPORPHYRIN IX CONTAINING FE, ... (4 entities in total)
Functional Keywordsoxidoreductase, monooxygenase
Biological sourceHOMO SAPIENS (HUMAN)
Cellular locationEndoplasmic reticulum membrane; Single-pass membrane protein: P08684
Total number of polymer chains1
Total formula weight56503.46
Authors
Sevrioukova, I. (deposition date: 2016-05-25, release date: 2017-06-07, Last modification date: 2024-01-10)
Primary citationGuo, Z.,Sevrioukova, I.F.,Denisov, I.G.,Zhang, X.,Chiu, T.L.,Thomas, D.G.,Hanse, E.A.,Cuellar, R.A.D.,Grinkova, Y.V.,Langenfeld, V.W.,Swedien, D.S.,Stamschror, J.D.,Alvarez, J.,Luna, F.,Galvan, A.,Bae, Y.K.,Wulfkuhle, J.D.,Gallagher, R.I.,Petricoin, E.F.,Norris, B.,Flory, C.M.,Schumacher, R.J.,O'Sullivan, M.G.,Cao, Q.,Chu, H.,Lipscomb, J.D.,Atkins, W.M.,Gupta, K.,Kelekar, A.,Blair, I.A.,Capdevila, J.H.,Falck, J.R.,Sligar, S.G.,Poulos, T.L.,Georg, G.I.,Ambrose, E.,Potter, D.A.
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
Cell Chem Biol, 24:1259-1275.e6, 2017
Cited by
PubMed Abstract: The mechanisms by which cancer cell-intrinsic CYP monooxygenases promote tumor progression are largely unknown. CYP3A4 was unexpectedly associated with breast cancer mitochondria and synthesized arachidonic acid (AA)-derived epoxyeicosatrienoic acids (EETs), which promoted the electron transport chain/respiration and inhibited AMPKα. CYP3A4 knockdown activated AMPKα, promoted autophagy, and prevented mammary tumor formation. The diabetes drug metformin inhibited CYP3A4-mediated EET biosynthesis and depleted cancer cell-intrinsic EETs. Metformin bound to the active-site heme of CYP3A4 in a co-crystal structure, establishing CYP3A4 as a biguanide target. Structure-based design led to discovery of N1-hexyl-N5-benzyl-biguanide (HBB), which bound to the CYP3A4 heme with higher affinity than metformin. HBB potently and specifically inhibited CYP3A4 AA epoxygenase activity. HBB also inhibited growth of established ER mammary tumors and suppressed intratumoral mTOR. CYP3A4 AA epoxygenase inhibition by biguanides thus demonstrates convergence between eicosanoid activity in mitochondria and biguanide action in cancer, opening a new avenue for cancer drug discovery.
PubMed: 28919040
DOI: 10.1016/j.chembiol.2017.08.009
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

236963

PDB entries from 2025-06-04

PDB statisticsPDBj update infoContact PDBjnumon